Antibacterial activity of a prophage lysin Sply828 from fish-derived Streptococcus parauberis

doi:10.13344/j.microbiol.china.210971

Home > Archive>Volume 49, Issue 5, 2022 >1719-1730. DOI:10.13344/j.microbiol.china.210971

Antibacterial activity of a prophage lysin Sply828 from fish-derived Streptococcus parauberis
DOI:
                        10.13344/j.microbiol.china.210971
                    
CSTR:
                        32113.14.j.MC.210971
                    
Author:
                        TU ChuandengTU Chuandeng
Marine Science & Technology Institute, College of Environmental Science and Engineering, Yangzhou University, Yangzhou 225127, Jiangsu, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
CHEN KaigeCHEN Kaige
Marine Science & Technology Institute, College of Environmental Science and Engineering, Yangzhou University, Yangzhou 225127, Jiangsu, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site

                    
Affiliation:
Clc Number:
Fund Project:

Article

Figures

Metrics

Reference [36]

Cited by

Materials

Comments

Abstract:

[Background] Streptococcus parauberis is a major aquatic pathogen which has gradually evolved new serotypes and multi-drug resistance. Therefore, it is urgent to develop a new antibacterial drug for the prevention and treatment of the disease caused by this pathogen. Studies have demonstrated that a lysin encoded by a prophage can effectively kill the host and has a good prospect of antibacterial application. [Objective] In this paper, we investigated the host spectrum of the prophage lysin from S. parauberis and optimized the conditions for the lytic activity. [Methods] We used bioinformatics tools to analyze the whole genomic sequence of the S. parauberis strain KRS02083 and discovered a lysin gene Sply828. By gene cloning, protein expression and purification, we obtained the lysin Sply828. We then evaluated the activities against different bacteria and the optimal lysis conditions of Sply828 by performing the turbidity decrease assay. [Results] Sply828 displayed the best activity against fish-derived S. parauberis and exhibited the highest activity against the bacteria in the exponential growth phase. This enzyme had the highest activity at 28 °C and pH 6.2, and its activity can be improved by Ca²⁺ and Mg²⁺ while inhibited by Zn²⁺, Cu²⁺, Fe²⁺, and Ni²⁺. [Conclusion] The prophage lysin Sply828 existing in the genomic sequence of S. parauberis possesses efficient and specific bactericidal activity, providing a preliminary basis for the prevention and control of the disease caused by S. parauberis.

Key words:Streptococcus parauberis;prophage;lysin;lytic activity

Reference

[1] Domeénech A, Derenaáandez-Garayzábal JF, Pascual C, Garcia JA, Cutuli MT, Moreno MA, Collins MD, Dominguez L. Streptococcosis in cultured turbot, Scopthalmus maximus (L.), associated with Streptococcus parauberis[J]. Journal of Fish Diseases, 1996, 19(1): 33-38

[2] Kanai K, Yamada M, Meng F, Takahashi I, Nagano T, Kawakami H, Yamashita A, Matsuoka S, Fukuda Y, Miyoshi Y, et al. Serological differentiation of Streptococcus parauberis strains isolated from cultured Japanese flounder in Japan[J]. Fish Pathology, 2009, 44(1): 33-39

[3] Lee CH, Kim PY, Ko CS, Oh DC, Kang BJ. Biological characteristics of Streptococcus iniae and Streptococcus parauberis isolated from cultured flounder, Paralichthys olivaceus, in JeJu[J]. Journal of fish pathology, 2007, 20(1): 33-40

[4] Hanol bektaş Z, Uçar FB, Savaşer S. Isolation and identification of Streptococcus parauberis from freshwater fish in Turkey[J]. Journal of Limnology and Freshwater Fisheries Research, 2017: 175-182

[5] Haines AN, Gauthier DT, Nebergall EE, Cole SD, Nguyen KM, Rhodes MW, Vogelbein WK. First report of Streptococcus parauberis in wild finfish from North America[J]. Veterinary Microbiology, 2013, 166(1/2): 270-275

[6] Mohammed HH, Peatman E. Winter kill in intensively stocked channel catfish (Ictalurus punctatus): Coinfection with Aeromonas veronii, Streptococcus parauberis and Shewanella putrefaciens[J]. Journal of Fish Diseases, 2018, 41(9): 1339-1347

[7] Torres-Corral Y, Santos Y. Comparative genomics of Streptococcus parauberis: new target for molecular identification of serotype III[J]. Applied Microbiology and Biotechnology, 2020, 104(14): 6211-6222

[8] Gao Y, Liu YK, Wang PM, Mo ZL, Li J, Liu SL, Li GY, Zhu M, Li J. Isolation, identification and vaccine development of serotype III Streptococcus parauberis in turbot (Scophthalmus maximus) in China[J]. Aquaculture, 2021, 538: 736525

[9] Meng F, Kanai K, Yoshikoshi K. Characterization of drug resistance in Streptococcus parauberis isolated from Japanese flounder[J]. Fish Pathology, 2009, 44(1): 40-46

[10] 周彪, 甄向凯, 欧阳松应. 噬菌体裂解酶应用研究进展[J]. 微生物学通报, 2021, 48(9): 3330-3340 Zhou B, Zhen XK, Ouyang SY. Research progress in the application of bacteriophage lysin[J]. Microbiology China, 2021, 48(9): 3330-3340 (in Chinese)

[11] Fischetti VA. Bacteriophage lysins as effective antibacterials[J]. Current Opinion in Microbiology, 2008, 11(5): 393-400

[12] 杜丽娟, 杨婷, 张宗德, 郭述良. 一种新型抗菌剂: 噬菌体裂解酶的研究进展[J]. 重庆医科大学学报, 2018, 43(7): 883-887 Du LJ, Yang T, Zhang ZD, Guo SL. Research progress of a novel antimicrobial agent-phage lytic enzyme[J]. Journal of Chongqing Medical University, 2018, 43(7): 883-887 (in Chinese)

[13] 刘畅, 沈瀚. 后抗生素时代的辅助抗菌策略研究进展[J]. 生物技术通讯, 2020, 31(6): 736-742 Liu C, Shen H. Advances of assisted antimicrobial strategies in the post-antibiotic era[J]. Letters in Biotechnology, 2020, 31(6): 736-742 (in Chinese)

[14] Pritchard DG, Dong SL, Kirk MC, Cartee RT, Baker JR. LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae[J]. Applied and Environmental Microbiology, 2007, 73(22): 7150-7154

[15] Celia LK, Nelson D, Kerr DE. Characterization of a bacteriophage lysin (Ply700) from Streptococcus uberis[J]. Veterinary Microbiology, 2008, 130(1/2): 107-117

[16] Oechslin F, Daraspe J, Giddey M, Moreillon P, Resch G. In vitro characterization of PlySK1249, a novel phage lysin, and assessment of its antibacterial activity in a mouse model of Streptococcus agalactiae bacteremia[J]. Antimicrobial Agents and Chemotherapy, 2013, 57(12): 6276-6283

[17] Lood R, Raz A, Molina H, Euler CW, Fischetti VA. A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia[J]. Antimicrobial Agents and Chemotherapy, 2014, 58(6): 3073-3084

[18] Xiao YY, Chen R, Li M, Qi ZT, Yu YF, Pan ZH, Yao HC, Feng ZX, Zhang W. The effectiveness of extended binding affinity of prophage lysin PlyARI against Streptococcus suis infection[J]. Archives of Microbiology, 2021, 203(8): 5163-5172

[19] Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJE. The Phyre2 web portal for protein modeling, prediction and analysis[J]. Nature Protocols, 2015, 10(6): 845-858

[20] Matamp N, Bhat SG. Phage endolysins as potential antimicrobials against multidrug resistant Vibrio alginolyticus and Vibrio parahaemolyticus: current status of research and challenges ahead[J]. Microorganisms, 2019, 7(3): 84

[21] Srinivasan R, Chaitanyakumar A, Subramanian P, Mageswari A, Gomathi A, Aswini V, Sankar AM, Ramya M, Gothandam KM. Recombinant engineered phage-derived enzybiotic in Pichia pastoris X-33 as whole cell biocatalyst for effective biocontrol of Vibrio parahaemolyticus in aquaculture[J]. International Journal of Biological Macromolecules, 2020, 154: 1576-1585

[22] Mishra A, Nam GH, Gim JA, Lee HE, Jo A, Kim HS. Current challenges of Streptococcus infection and effective molecular, cellular, and environmental control methods in aquaculture[J]. Molecules and cells, 2018, 41(6): 495-505

[23] Gilmer DB, Schmitz JE, Euler CW, Fischetti VA. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus[J]. Antimicrobial Agents and Chemotherapy, 2013, 57(6): 2743-2750

[24] Huang L, Luo DH, Gondil VS, Gong YJ, Jia MH, Yan DZ, He J, Hu SC, Yang H, Wei HP. Construction and characterization of a chimeric lysin Cl_yV with improved bactericidal activity against Streptococcus agalactiae in vitro and in vivo[J]. Applied Microbiology and Biotechnology, 2020, 104(4): 1609-1619

[25] Pritchard DG, Dong SL, Baker JR, Engler JA. The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30[J]. Microbiology, 2004, 150(7): 2079-2087

[26] Gu JM, Xu W, Lei LC, Huang J, Feng X, Sun CJ, Du CT, Zuo J, Li Y, Du TF, et al. LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection[J]. Journal of Clinical Microbiology, 2011, 49(1): 111-117

[27] Daniel RM, Peterson ME, Danson MJ, Price NC, Kelly SM, Monk CR, Weinberg CS, Oudshoorn ML, Lee CK. The molecular basis of the effect of temperature on enzyme activity[J]. The Biochemical Journal, 2009, 425(2): 353-360

[28] Loeffler JM, Djurkovic S, Fischetti VA. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia[J]. Infection and Immunity, 2003, 71(11): 6199-6204

[29] Fenton M, Ross RP, McAuliffe O, O’Mahony J, Coffey A. Characterization of the staphylococcal bacteriophage lysin CHAPK[J]. Journal of Applied Microbiology, 2011, 111(4): 1025-1035

[30] Zhao YJ, Zhang YH, Cao Y, Qi JX, Mao LW, Xue YF, Gao F, Peng H, Wang XW, Gao GF, et al. Structural analysis of alkaline β-mannanase from alkaliphilic Bacillus sp. N16-5: implications for adaptation to alkaline conditions[J]. PLoS One, 2011, 6(1): e14608

[31] Filatova LY, Donovan DM, Foster-Frey J, Pugachev VG, Dmitrieva NF, Chubar TA, Klyachko NL, Kabanov AV. Bacteriophage phi11 lysin: physicochemical characterization and comparison with phage phi80α lysin[J]. Enzyme and Microbial Technology, 2015, 73/74: 51-58

[32] Gu JM, Feng YG, Feng X, Sun CJ, Lei LC, Ding W, Niu FF, Jiao LY, Yang M, Li Y, et al. Structural and biochemical characterization reveals LysGH15 as an unprecedented “EF-hand-like” calcium-binding phage lysin[J]. PLoS Pathogens, 2014, 10(5): e1004109

[33] Loessner MJ, Wendlinger G, Scherer S. Heterogeneous endolysins in Listeria monocytogenes bacteriophages: a new class of enzymes and evidence for conserved holin genes within the siphoviral lysis cassettes[J]. Molecular Microbiology, 1995, 16(6): 1231-1241

[34] Xu XL, Zhang DD, Zhou B, Zhen XK, Ouyang SY. Structural and biochemical analyses of the tetrameric cell binding domain of Lys170 from enterococcal phage F170/08[J]. European Biophysics Journal, 2021, 50(5): 721-729

[35] Roach DR, Donovan DM. Antimicrobial bacteriophage- derived proteins and therapeutic applications[J]. Bacteriophage, 2015, 5(3): e1062590

[36] Zhang HM, Buttaro BA, Fouts DE, Sanjari S, Evans BS, Stevens RH. Bacteriophage φEf11 ORF28 endolysin, a multifunctional lytic enzyme with properties distinct from all other identified Enterococcus faecalis phage endolysins[J]. Applied and Environmental Microbiology, 2019, 85(13): e00555-19

Get Citation

TU Chuandeng, CHEN Kaige. Antibacterial activity of a prophage lysin Sply828 from fish-derived Streptococcus parauberis[J]. Microbiology China, 2022, 49(5): 1719-1730

Copy

Article Metrics

Abstract:287
PDF: 778
HTML: 916
Cited by: 0

History

Received:October 18,2021
Revised:
Adopted:January 12,2022
Online: May 05,2022
Published:

Get Citation

Share

Article Metrics

History

Article QR Code